It should be noted, however, that previous research has suggested that IL33 and IL4 are not crucial for the beneficial effects of IVIg in murine ITP models, and patients with ITP still respond to IVIg after splenectomy (20, 21). The gene discussed is IL4; the disease is autoimmune thrombocytopenic purpura.